Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hata

Showing results (191-200 of 264) with videos related to

Pageof 27
Sort By:
Neurosurgery|April 27, 2001
Serial intraoperative magnetic resonance imaging of brain shiftA Nabavi, P M Black, D T Gering, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2016
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune MicroenvironmentTiffany G Huynh, Vicente Morales-Oyarvide, Meghan J Campo, et al.
Oncogene|August 8, 2017
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancersA N Hata, S Rowley, H L Archibald, et al.
JCO Precision Oncology|April 30, 2019
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed <i>EGFR</i> Mutant Non-Small-Cell Lung CancerMeghan J Mooradian, Zofia Piotrowska, Benjamin J Drapkin, et al.
The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.
Nature Communications|October 2, 2022
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimeticsCameron S Fraser, Johan K E Spetz, Xingping Qin, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung CancerTakashi Sakai, Zofia Piotrowska, Charlotte I Wang, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
Regional differences in homicide patterns in five areas of JapanN Hata, Y Kominato, I Shimada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation DiversityIbiayi Dagogo-Jack, Marguerite Rooney, Jessica J Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2024
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450]Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Pageof 27

Showing results (191-200 of 264) with videos related to

Sort By:
Pageof 27
Neurosurgery|April 27, 2001
Serial intraoperative magnetic resonance imaging of brain shiftA Nabavi, P M Black, D T Gering, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2016
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune MicroenvironmentTiffany G Huynh, Vicente Morales-Oyarvide, Meghan J Campo, et al.
Oncogene|August 8, 2017
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancersA N Hata, S Rowley, H L Archibald, et al.
JCO Precision Oncology|April 30, 2019
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed <i>EGFR</i> Mutant Non-Small-Cell Lung CancerMeghan J Mooradian, Zofia Piotrowska, Benjamin J Drapkin, et al.
The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.
Nature Communications|October 2, 2022
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimeticsCameron S Fraser, Johan K E Spetz, Xingping Qin, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung CancerTakashi Sakai, Zofia Piotrowska, Charlotte I Wang, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
Regional differences in homicide patterns in five areas of JapanN Hata, Y Kominato, I Shimada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation DiversityIbiayi Dagogo-Jack, Marguerite Rooney, Jessica J Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2024
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450]Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Pageof 27